Kalaris Therapeutics (KLRS) Current Assets (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Current Assets data on record, last reported at $383.9 million in Q3 2020.
- For Q3 2020, Current Assets changed N/A year-over-year to $383.9 million; the TTM value through Sep 2020 reached $383.9 million, changed N/A, while the annual FY2019 figure was $127.3 million, N/A changed from the prior year.
- Current Assets reached $383.9 million in Q3 2020 per KLRS's latest filing, up from $107.3 million in the prior quarter.
- Across five years, Current Assets topped out at $383.9 million in Q3 2020 and bottomed at $107.3 million in Q2 2020.